Fresh2 Group Limited (NASDAQ: FRES)
$1.1300
+0.2800 ( +0.89% ) 285.1K
Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.
Market Data
Open
$1.1300
Previous close
$0.8500
Volume
285.1K
Market cap
$2.09M
Day range
$0.5550 - $1.3850
52 week range
$0.7343 - $9.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 3 | Insider transactions | 1 | Jan 26, 2024 |
| 3/a | Insider transactions | 1 | Jan 16, 2024 |
| 20-f/a | Annual reports | 130 | Jan 09, 2024 |
| 3 | Insider transactions | 1 | Jan 05, 2024 |
| 6-k | Form 6-K | 2 | Dec 15, 2023 |
| 6-k | Form 6-K | 7 | Dec 06, 2023 |
| 6-k/a | Form 6-K | 105 | Dec 04, 2023 |
| 6-k | Form 6-K | 4 | Dec 04, 2023 |